GW Vaccine Research Unit

Washington D.C., District of Columbia 20037

1 studies enrolling now · 5 studies all time

What they study most

COVID-19, Clostridioides Difficile Associated Disease, Herpes Zoster Infection, Human, Influenza, Human, RESPIRATORY SYNCYTIAL VIRUS (RSV), SARS-COV-2 Infection, SARS-CoV-2 Infection, Shingles

Studies at this site

• A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older — Recruiting now
• A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years — Completed
• A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults — Stopped early
• A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults — Completed
• A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease — Completed